Clinical trial
CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant
NCT00369291 · Masonic Cancer Center, University of Minnesota, Other · Terminated
Key facts
| NCT number | NCT00369291 |
|---|---|
| Title | CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant |
| Official title | CPG 7909 Oligodeoxynucleotides (ODNS) After Autologous Transplantation to Enhance Immune Reconstitution |
| Lead sponsor | Masonic Cancer Center, University of Minnesota, Other |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Germ Cell Tumor, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm |
| Intervention type | Biological |
| Interventions | keyhole limpet hemocyanin, tetanus toxoid |
| Enrollment | 19 |
| Start date | Sep 1, 2003 |
| Primary completion | May 1, 2010 |
| Completion | May 1, 2010 |
| First posted | Aug 29, 2006 |
| Last update posted | Nov 29, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: